Aroa Biosurgery Concludes Successful Trial for Symphony™: Promising Results Indicate Meeting of Primary Endpoint Aroa Biosurgery has successfully completed its randomized controlled trial for Symphony™, showing promising preliminary results that indicate the primary endpoint was met, enhancing treatment options for diabetic foot ulcers.

Aroa Biosurgery Concludes Successful Trial for Symphony™: Promising Results Indicate Meeting of Primary Endpoint #Diabetic_Foot_Ulcers #New_Zealand #Auckland #Aroa_Biosurgery #Symphony

Aroa Biosurgery's Myriad™ Shows Promise in Trauma Surgery and Cost Effectiveness Aroa Biosurgery’s recent study highlights Myriad™'s effectiveness in trauma care. The findings reveal significant cost savings while ensuring optimal healing for patients.

Aroa Biosurgery's Myriad™ Shows Promise in Trauma Surgery and Cost Effectiveness #New_Zealand #Auckland #Aroa_Biosurgery #Myriad_Matrix #MASTRR_study

Aroa Biosurgery Validates Endoform's Efficacy for Vein Ulcers with Real-World Study Aroa Biosurgery announces significant findings from a real-world study validating their product Endoform for treating venous leg ulcers.

Aroa Biosurgery Validates Endoform's Efficacy for Vein Ulcers with Real-World Study #New_Zealand #Auckland #Aroa_Biosurgery #Endoform #Venous_Leg_Ulcers

New Study Confirms Myriad™ Technology Benefits in Limb Salvage Procedures A recent study highlights the clinical and economic advantages of Myriad™ technology in lower limb salvage surgeries, showcasing its efficacy and cost-effectiveness.

New Study Confirms Myriad™ Technology Benefits in Limb Salvage Procedures #New_Zealand #Auckland #Aroa_Biosurgery #Myriad_Matrix #Limb_Salvage